FDA Drug Application (091616) for LITHIUM CARBONATE by GLENMARK GENERICS

Back to FDA Applications sponsored by GLENMARK GENERICS

Application Number091616
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage450MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLITHIUM CARBONATE
Active IngredientLITHIUM CARBONATE



Back to FDA Applications sponsored by GLENMARK GENERICS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.